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The reactivity of lys-126 in glutamate dehydrogenase was investigated by
monitoring the loss of enzymatic activity when lys-126 is modified by pyridoxyl
5'
phosphate. The effect of various ligands on the rate constant of inactivation
OWt) was determined. The purine nucleotides ADP and GTP increased the k^t,
glutarate slightly increased the k^.^ , 2-oxoglutarate and succinate were determined
to have no effect on k^t and no conclusions could be drawn on L-2-
hydroxyglutarate. After the modification of glutamate dehydrogenase with
pyridoxyl
5'
phosphate, the percent residual activity (%R.A.) was determined and
evaluated. ADP, GTP and succiante had no effect on the %R.A, glutarate and 2-
oxoglutarate significantly increased the %R.A. No conclusions could be drawn
about the effect of L-2-hydroxyglutarate. Modification of lys-126 by pyridoxyl
5'
phosphate is reversible, so the effects of the various ligands on the rate constant of
reactivation (k^^ was also invesitagted. Both the purine nucleotides, ADP and
GTP, as well as the substrate analogs, glutarate, succinate, L-2-
hydroxyglutarate,and 2-oxoglutarate, had no effect on the rate constant of
reactivation.
Using ion exchange chromatography, a protocol for separating NAD
+ from
NADP+
was determined. This separation is a necessary step for the enzymatic
synthesis of a selenium
NADP+
analog for X-ray crystallography.
INTRODUCTION
Reactivity of Lys-126
Glutamate dehydrogenase (E.C. 1.4.1.3) is a complex allosteric enzyme that
catalyzes both the oxidative deamination of glutamate and the reductive animation
of0(-ketoglutarate thus providing a link between the citric acid and urea cycles.
Gluatmate + NAD(P)
+ + H2Q ^ ^ (fcKetoglutarate + NAD(P)H
-I- NH4+




of either NAD + or NADP+ will be abbreviated NAD(P)+) with an equal affinity,
glutamate dehydrogenase has been extensively studied. (1,2) Glutamate
dehydrogenase is thought to play an important role in ammonia metabolism.
Carbamoylphosphate synthase, N-acetylglutamate synthase and glutamate
dehydrogenase are all mitochondrial enzymes involved in the regulation of ammonia
metabolism/3) Through the concerted action of these enzymes, the urea cycle is
indirectly controlled. Because glutamate dehydrogenase catalyzes a reaction at, or
near equilibrium, in vivo, any increase in the concentration of ammonia results in
the activation of the reductive amination reaction of glutamate dehydrogenase
causing an increase in the concentration of
glutamate/3) N-acetylglutamate
synthase then utilizes glutamate to form N-acetylglutamate/3) N-acetylglutamate is
an absolutely required allosteric regulator of, and stimulates carbamoylphosphate
synthase activity resulting in carbamoylphosphate being produced, which in turns
activates the urea cycle/3) Therefore the major role of glutamate dehydrogenase
seems to be the rapid removal of ammonia in the mitochondrial matrix/3) Elevated
2
levels of ammonia have been shown to inhibit the ability of the mitochondrion to
produce ATP/4) Thus glutamate dehydrogenase serves to maintain the ability of
the mitochondrion to produce ATP/3)
Glutamate dehydrogenase consists of six chemically identical polypeptide
chains consisting of 501 residues per chain/5) By electron microscopy,
sedimentation and viscosity studies as well as guanidine chloride denaturation,
glutamate dehydrogenase has been found to be arranged as a dimer of trimers/6)
Chemical crosslinking confirmed the hexameric structure with D3 symmetry (7) of
molecular weight 336 KDa/8-9) The hexamer form of the enzyme can be
reversibly dissociated into trimers with guanidine hydrochloride/8) However from
the construction of heterohexamers which consist of one native trimer and one
modified, inactive trimer, it was discovered that the hexamer is required for cata
lytic activity/9) A concentration dependent polymerization is observed although
this polymerization does not affect the activity or regulatory properties of the
enzyme/10"18)
The regulation of glutamate dehydrogenase is complex and, as of yet, not
fully understood. From initial rate studies of the oxidative deamination reaction of
glutamate dehydrogenase, non-linear Lineweaver-Burke plots were obtained when
the concentration of the glutamate was fixed with the concentration of either
NAD+
or
NADP+ varied/19) To explain this phenomena, Dalziel and Engel
proposed that it was a result of negative cooperativity between the presumably six
identical subunits/20-21) Upon re-examination of the initial rate data, Dalziel and
Engel suggested that the negative cooperativity must be a result of both negative
and positive interactions between subunits/22) They also proposed that this
negative cooperativity must involve both the
catalytic step and the coenzyme
binding step/22) Evidence supporting the assumption that the binding of the
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coenzyme was involved was reported by Bell and Dalziel. They found that upon
binding either the oxidized or reduced coenzyme to half of its subunits in the
presence of glutarate, a catalytically inactive substrate analog of glutamate, a
conformational change on the second half of the hexamer resulted/23)
Involvement of the catalytic step was determined using the thionicotinamide
analogs of
NAD+
and NADP+. Thio-NAD+ and thio-NADP+ have been
proven to accurately mimic the behavior of the natural coenzymes
NAD+
and
NADP+/24) The reduced form of thio-NAD(P)+ has an absorption maxima at
400 nm with very little absorbance at 340 nm while
NAD(P)+ has an absorption
maxima at 340 nm with insignificant absorption at 400 nm. This difference in the
absorption spectra allows for the use of dual wavelength spectroscopy to monitor
the utilization of both the natural cofactor and the thionicotinamide analog of the




simultaneously the Lineweaver-Burke plot is linear.
At low concentrations of the cofactor whose activity is being monitored, its
utilization is decreased compared to when it is presented to glutamate
dehydrogenase alone. At high concentrations, the utilization of the cofactor whose
reduction was being monitored was increased in comparison to the presence of only
a single cofactor. Since the two cofactors can not be in the active site at the same
time, this indicates that upon binding of the second coenzyme to a different subunit,
a conformational change must occur across subunit interfaces of the hexamer of
glutamate dehydrogenase affecting the utilization of the other coenzyme. This
demonstrates that within the catalytically functioning enzyme, there are negatively
cooperative interactions. Subsequent studies using substrate analogs suggested that
the 2-position in glutamate was responsible for the induction of the conformation
change attributed to the negative cooperativity of glutamate
dehydrogenase/25)
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Regulation of glutamate dehydrogenase by the purine nucleotides GTP and
ADP seem to have opposing effects on the activity of glutamate dehydrogenase.
GTP is a potent inhibitor of the enzyme/26) The inhibition by GTP seems to be a
consequence of stabilizing a glutamate dehydrogenase-NADH-glutamate abortive
complex. This abortive complex appears to play a role in the normal catalytic cycle
at pH values above 7.0. ADP alone acts as an activator by destabilizing this
complex at pH values above 7.0. ADP can also relieve the inhibition of GTP at all
pH values by displacing it from its binding site and destabilizing this abortive
complex, even though at low pH values, ADP, in the absence of other regulators,
acts as an inhibitor/3) This inhibition appears to be a result of competition between
ADP and NAD(P)+ for the coenzyme binding site/3) Competitive inhibition with
respect to the coenzyme of glutamate dehydrogenase by ADP is also observed at
high concentrations of ADP/3) At either high or low pH values in the presence of
ADP, the non-linear Lineweaver-Burke plots obtained with
NAD(P)+
as the
varied substrate are linear suggesting that ADP removes the negative cooperativity
of glutamate dehydrogenase/3)
In order to understand the complex, allosteric regulation of glutamate
dehydrogenase, chemical modification studies have been used to investigate the
local structure around substrate and regulatory binding sites. These studies also
assessed the accompanying changes in the conformation of the enzyme upon
binding of these ligands. Talbot, et. al/27) identified two lysine residues, lys-126




phosphate reacts specifically with lysine residues forming a reversible Scruff s base
(figure 1). Using protecting ligands, selective modification of one of the two
lysines showed that lys-333 is involved in the ability of the enzyme to further








Lys-NH3+ + Q=<y >Lys-NH=C<
^react
Figure 1:
Formation of Schiffs base between pyridoxyl
5'
phosphate and Iysine-126 in
the active site of glutamate dehydrogenase. Top picture done on Alchemy.
in the loss of catalytic activity/27)
Lys-126 was originally proposed to interact with the one position carboxyl
group of dicarboxylic acid substrates/25) Recent studies in our lab however, have
suggested that lys-126 interacts with the
5'
carboxyl of glutamate or a-ketoglutarate.
The reactivity of this lysine however has not been extensively investigated. The
goal of the current work was to characterize the stability of the Schiffs base
formed between pyridoxal
5'
phosphate and lys-126. The effects of various
substrate analogs and regulators on its stability were investigated.
Preparation of Selenium NADP+ Analog
With the question, "What would happen if the wavelength of the X-ray is
smaller than the repeat distance in a crystal?", Laue founded the science of X-ray
crystallography/28) Friedrich and Knipping answered this question when they
successfully recorded the diffraction pattern of CUSO45H2O in
1912/28) W.L.
Bragg provided an explanation for the diffraction pattern of an X-ray caused by a
crystal lattice at about the same time/28) Since these early days in the history of
X-
ray crystallography, many advances both in this field and in the fields of
mathematics and computer science have made the structure determination of small
crystals by X-ray crystallography an almost trivial task. Crystallography gives a
very detailed structure of
small molecules with resolutions up until 0.01
angstroms/29) Because of this and due to the relative ease of solving structures
with the aid of the computer program packages now available, chemists are
increasingly bypassing traditional methods of characterization such as NMR and IR,
for X-ray crystallography when the product is easily crystallized.
The recent advances in X-ray crystallography makes it one of the most
powerful tools available for elucidating the structure of molecules. With the
realization that proteins are ordered in a crystal lattice, came the possibility that
protein structures could be solved using X-ray diffraction/28) X-ray
crystallography has the possibility of giving a very detailed three-dimensional
picture of the structure of a protein, while other commonly used methods for
getting structural information give just pieces of the puzzle. These pieces then have
to be fit together in order to get only a rough sketch of the overall structure of the
molecule.
Despite the promise of getting a very detailed picture of the placement of
the atoms of a protein in space by X-ray crystallography, proteins introduce many
complications into the experiment. Proteins typically are composed of about fifty
percent water and lose their crystallinity when dehydrated/28) This results in
proteins crystals being generally less ordered than small molecules so that atomic
resolution is often not possible/28) On top of poor resolution, the phase problem of
all X-ray crystallography experiments is even more of a challenge with proteins
because the methods used for small molecules such as the direct method and
Patterson methods get impossibly complicated for proteins/28) Also, because
protein molecules contain a large number of atoms, there is a large number of
X-
ray diffraction measurements that
have to be made. The intensities of these
diffracted beams being less than that of beams diffracted from small molecules
further complicating data
collection/28)
In spite of the many obstacles that need to be overcome, protein chemists
have been able to solve the structures of proteins using X-ray crystallography.
However, the use of this technique is limited by two factors: 1) the need for a
crystal and 2) the fact that the X-ray method is essentially static where as biological
processes are dynamic/28)
In order to perform a crystallography experiment, a reasonably sized crystal
of very high purity has to be available. The necessity of a crystal is a major
constraint on the usage of this technique since many large macromolecules can not
be crystallized. Also the conditions used to crystallize proteins are usually very
harsh which raises questions as to the validity of the structure obtained/29) First
does the structure represent the structure of the native protein? Secondly do the
conditions used to crystallize the protein affect the three dimensional structure?
Studies done on the activity of ribonuclease, carboxypeptidase, chymotrypsin,
papain, and alcohol dehydrogenase in the crystalline form have shown that the
crystal structure represents the structure of the functioning enzyme/29) and
chymotrypsin, despite their nearly identical amino acid sequence crystallize under
quite different conditions but have been found to have essentially the same tertiary
structure suggesting that crystallization conditions have tittle if any effect on the
three dimensional structureof these molecules/29)
The static nature of X-ray diffraction puts limitations on the type of
information that may be obtained. In order to perform an X-ray crystallography
experiment, several days are needed to record the
data/28) Because of this, the
structure obtained is only an average structure over the time period of data collec
tion. Due to the nature of the X-ray experiment, different conformations an
enzyme may assume during its function could not be investigated using this
technique/29)
The X-ray analysis of a protein usually consists of eight steps outlined in
figure 2.
Grow crystals








Figure 2: Steps in the structure determination of a protein by X-ray crystallography.
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The major problem in an X-ray diffraction experiment is that only the
intensity of the diffracted rays are recorded. However in order to determine the
structure from the diffraction pattern both the intensity and the phase of the
diffracted rays have to be known/28) Possibly one of the most frustrating and
challenging aspect of an X-ray analysis is the determination of the phases of the dif
fracted rays. Four methods are available to overcome the phase problem for small
crystals. However two of these methods, the direct method and the Patterson
summation, are not suitable for determining the phases of diffracted rays in the
analysis of protein because they get too complicated. The two other methods,
heavy atom isomorphous replacement and anomalous scattering, have been
successfully used in protein structure determination by X-ray crystallography.
Heavy atom isomorphous replacement involves introducing a heavy atom
into the crystal. A perfect isomorphous derivative is one where the only change in
the electron density between the derivative and the crystal is at the site of the heavy
atom substitution/28) In small molecules this is easily achieved by replacing an
atom with a similar but more electron dense atom such as replacing sulfur with a
selenium, or bromine with an
iodine/28) Usually a different approach has to be
taken with proteins because the atoms are covalently attached which makes it
difficult to replace just one atom. A more common technique that is used to
introduce heavy atoms into the protein is to diffuse a heavy atom salt into the
protein and hope that the salt chelates to a unique amino acid side chain/28) This
method is obviously a hit and miss approach and may also
further complicate the
phasing of the diffracted rays if the heavy atom binds at many different points in the
protein/28)
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Enzymes and carrier proteins offer alternative methods of introducing heavy
atom probes into the crystal/28) If the specificity of the active site of an enzyme
or carrier protein is known, a heavy atom analog of the substrate can often be used
in the determination of the phases/28) Frequently proteins and enzymes have metal
ions associated with them. If these metal ions can be removed and replaced with a
heavier metal ion, then the phases can be solved from these heavy atom
derivatives/28) Recently site directed mutagenisis was used to specifically change a
sulfur in methionine to selenium giving a selenomethione residue/30) However,
isomorphous replacement of a sulfur to selenium in the protein does not result in
enough of a difference in the electron density to allow its routine use as an adequate
heavy atom derivative for phase determination/30)
On account of the difficulties encountered in the determination of phases in
the elucidation of the structure of a protein by X-ray crystallography, new
techniques are constantly being sought to solve the 3-dimensional structure of a
protein. Dehydrogenases are an important class of enzymes that have been
extensively studied. The dehydrogenases provide a source of high potential
hydrogen atoms that are essential in biosynthetic pathways for the reduction of
double bonds/31) Until this point in time only the crystal structures of
NAD+-
dependent dehydrogenases have been solved. From the structures of these NAD+-
dependent dehydrogenases, all have been determined to have a common motif in the
binding site for NAD"1". The pyridine nucleotide binding domain consists of a
series of beta-pleated sheets that are connected by helical regions or loops of
polypeptide chains with an angle of twist between sheets of 100 degrees/29) This
is illustrated in figure 3. Root mean square deviations between equivalent atoms
12
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indicate that there is structural homology between equivalent atoms in the NAD+
binding domain/29) In spite of this marked structural homology, there is very little
sequence homology in this region/29) Only five out of the twenty residues that
make up the Rossman fold are conserved/29) Three of these residues, gly-25,
gly-33 and asp-53 (from the lactate dehydrogenase sequence), have a specific
function/29) Gly-25 and gly-33 are required in order to let the -A sheet lie in the
proper orientation/29) Gly-25 is required because if any other amino acid was at
position 25 the carbon of the side chain would overlap with the C2 carbon of the
adenine moiety of
NAD+
and prevent it from binding in the orientation necessary
for catalytic activity/29) The carboxyl group of asp-53 has been determined to help
facilitate the binding of
NAD+
by forming a hydrogen bond with the oxygen on
the adenine ribose moiety/29) Asp-53 may also be important in the specificity of
an enzyme for NAD+ over NADP+. NADP+ has an extra phosphate attached to
the adenine ribose ring so that it can not form this hydrogen bond.
Due to the marked structural homology between the binding sites for
NAD"1"
in NAD+-dependent dehydrogenases and many other
NAD+
utilizing
enzymes whose structures have been solved, it is of great interest to determine if an
NADP+
equilavalent of the Rossman fold exists. Additionally, another question




or vice versa or better yet how can an enzyme utilize either NAD+
or
NADP+ but with differing selectivity?
The only difference in the structure of
NAD+
and
NADP+ is that NADP+
has a phosphate group on the C2 carbon of the adenine ribose moiety whereas
NAD+ has a hydroxyl group (see figure 4). In the binding domain for
NAD+
an
aspartate residue is oriented in such a way as to be able to form a hydrogen bond
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Nicotinamide Adenine Diphosphate Phosphate (NADP+)
Figure 4: Structures ofNAD+ and NADP+.
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with the hydroxyl group on the C2 of NAD
+
which has been shown to help




can not form this hydrogen bond
with the aspartate residue due to the fact that this hydroxyl group is phosphorylated.
This aspartate residue suggests a potential site responsible for forming an interaction
that confers specificity. The question that now needs to be addressed is whether
just one residue forming one interaction is enough to give an enzyme the ability to
use one cofactor over the other or are there other structural features that determine
the specificity for co-enzyme?
In order to answer this question the crystal structure of NADP+ -dependent
enzymes and those that can use either NAD+ or NADP+ need to be solved.
Glutamate dehydrogenase and glucose-6-phosphate dehydrogenase appear to be





with an equal affinity while glucose-6-phosphate
dehydrogenase can utilize either NAD+ or NADP, but binds to
NADP+
with an
affinity one thousand times greater than
NAD+/32) Both these enzymes have
recently been crystallized after many decades of unsuccessful trials. Despite the
fact that crystals are now available, the crystal structures have not been solved due
to the lack of a heavy atom derivative needed to solve for the phases of the
diffracted beams.
Heavy atom derivatives of substrates and inhibitors of enzymes are
commonly used as probes for
their structure in an X-ray crystallography
experiment/28) Problems however often accompany this approach. Frequently the
inhibitor-enzyme complex is not completely isomorphous with the native enzyme.
Usually this is a result of an induced
conformational change in the enzyme upon
binding of the substrate or inhibitor. When a conformational change occurs and the
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data from the derivative is combined with that of the native enzyme, errors occur in
the phase determination resulting in an inaccurate picture of the enzyme.
For example, Chymotrypsin has an active site serine residue which was
modified to give a series of inhibited-enzyme complexes, the tosyl, BSF and
pipsyl(28) derivatives. These derivatives proved to be isomorphous with each other
but not with the native enzyme. To overcome this problem, the tosyl derivative
was used as the parent protein in the phase determination step. However using a
inhibitor-enzyme complex as the parent compound in the phase determination leads
to problems in the interpretation of the structure obtained. A major goal of any
X-
ray experiment is the determine the orientation of amino acid side chains in the
active site of a protein. Inhibitor molecules may interfere with the correct
orientation of these side chains in the active site and thus give a poor representation
of these residues in the catalytically active form of the enzyme.
The probe proposed to be used as a heavy atom derivative in the
isomorphous phase determination of an X-ray crystallography experiment to solve
the structure of
NADP+
-dependent enzymes is 0-Se-NADP+ (see figure 5).
Glutamate dehydrogenase is of interest due to its unique ability to exploit either
NAD+ or NADP+ with equal affinity/32)
NAD(P)+ is used as a cofactor in the
oxidative deamination of glutamate and functions by transferring a hydride radical
to the nicotinamide moiety resulting in the 1,4-dihydronicotinamide ring system as
shown in figure 6/33) The adenine ribose portion of NAD(P)
+ is thought to be
important in the interactions involved in the binding of the cofactor to the
enzyme/33) Changing the nicotinamide moiety of NAD(P)
+
should not change the
interactions needed for the specificity of an enzyme for one cofactor over another
but depending on the type of change may affect the ability of the cofactor to be










Figure 5: The proposed heavy atom affinity probe to be used to solve the crystal
structure ofNADP+ dependent enzymes. 0-Se-NADP+. The
nicotinamide ring is replaced with a five membered ring containing
selenium. Both the nicotinamide ring and the new ring systems
are aromatic.
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ions resulting in the reduction of the nicotinamide ring system to the 1,4-
dihydronicotinamide ring system/33)
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figure 7) has been shown to be catalytically active because the modified
nicotinamide ring is still able to be reduced.
Using the binary NAD
+
-glutamate dehyrogenase complex as the parent
protein in an X-ray experiment, thio-NAD(P)
+
would probably not be a good
probe due to the fact that a carbon to sulfur replacement in the past has been found
not to cause enough change in electron density/30) Seleno-NAD+ has also been
made and has been found to inhibit glutamate dehydrogenase competively with
NAD+ thus indicating that it binds to the enzyme at the same binding site as
NAD"1". If the binary NAD
+
-glutamate dehyrogenase complex is used as the
parent protein for phase determination, then the carbon to selenium replacement
would probably provide enough difference in electron density to resolve the phases.
However,
Se-NAD+
would not be a good probe for the structure of glutamate
dehydrogenase for two reasons. First, glutamate dehydrogenase has two binding
sites for NAD"1", a regulatory site and the catalytic site. Therefore two or more
different derivatives are possible with some sites not being fully saturated making
the determination of phases more difficult. The second reason is that the probe
needs to be covalently attached to the enzyme. Periodate
oxidation of NAD(P)
+
(figure 8a) will convert the diol to a dial which then could form a Schiffs base with
any lysine residue which may
be in the site (figure 8b). Reduction with sodium
borohydride (figure 8c) would covalently attach the probe.
NAD4"
has two
different diols one on the nicotinamide ribose and one on the adenine ribose both of
which could undergo periodate oxidation causing two possible products.
NADP+
only has the diol on the
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Figure 8: Attachment ofHeavy Atom Probe
a)Periodate treatment of a cis diol results in the hydroxyl groups being oxidized to
aldehyde groups.
b) The resulting aldehydes can form a Schiffs base with any nearby amine groups.
c)Sodium borohydride reduction reduces the double nitrogen to carbon bond in the
Schiffs base to a single nitrogen to carbon bond.
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In the X-ray experiment to solve the crystal structure of glutamate
dehydrogenase, the reduced binary
0-NADP+
-glutamate dehydrogenase complex
will be the parent complex and the reduced binary
0-Se-NADP+
-glutamate
dehydrogenase complex will be the heavy atom isomorphous derivative used to
solve the phase problem inherent in the diffraction pattern. While 0-Se-NADP+ is
most likely an inhibitor of glutamate dehydrogenase, there should be very little
difference in the conformation of glutamate dehydrogenase when bound to either O-
NADP+
or 0-Se-NADP+ in view of the fact the difference is in the catalytic
portion of the cofactor and not the portion responsible for the interactions needed to
bind to the enzyme. These are the interactions that would most likely be responsible
for triggering any conformational changes. 0-Se-NADP+, at least on paper,
seems to be a reasonable probe for the structure of NADP+-dependent enzymes.
The protocol for synthesizing
























Bovine liver L-glutamate dehydrogenase (EC 1.4.1.3) was obtained from
Sigma Chemical Company (St. Louis, MO, U.S.A.) as a 67 mg/ml solution in 50%
glycerol containing sodium phosphate buffer, pH 7.3. Before use the enzyme was
diluted to a stock solution of 2 mg/ml in 0.1 M phosphate buffer, pH 7. The
enzyme concentration used for the inactivation was estimated using an extinction
coefficient of 0.93 cm_1*(mg/ml)"l for a 1 mg/ml solution at 280 nm/33) All
buffer salts with the exception of sodium dihydrogen phosphate, substrates,
cofactors and modulators were purchased from Sigma Chemical Company and
made up fresh just before use in 0. 1 M phosphate buffer, pH 7. The phosphate
buffer was made with sodium diphosphate, monohydrate in the crystalline form
purchased from J.T. Baker Chemical Company (Phillipsburg, N.J., U.S.A.). The
standard assay mixture used for rate measurements consisted of 20
mM glutamate
and 250 M NAD+ in 0.1 M phosphate buffer, pH 7. The cuvettes used in rate
measurements were supplied by Sarstedt Company (Pennsauken, N.J., U.S.A.).
Methods
All enzyme activity measurements were
performed using the
SLM-
AMINCO 3000 Array spectrophotometer (SLM-AMINCO3000). Because the
cuvettes used absorb at 340 nm but not at 360 nm, the OD was monitored at 360
nm to monitor for NADH production as opposed to 340 nm. The slope of the
absorbance at 360 nm vs time graph was determined using the rate analysis program
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in the applications package of the SLM-AMINCO3000. The absorbance of a 1
mg/ml NADH solution was measured both at 340 nm and 360 nm. Since the
absorbances at both wavelengths were within three percent of one another, the rate
of enzyme activity was found by dividing the slope of the absorbance vs time line
by the extinction coefficient of NADH at 340 nm, 6.22 cm"1/35) The rates of
inactivation and reactivation were found by fitting the rate of enzyme activity vs
time graph to the exponential function, y=Aoe(-kt) + B where A0 is the amplitude
of the exponential; k is the rate of either inactivation or reactivation; t is the time
and B is the residual activity, using SigmaPlot 4.0 (Jandel Scientific, CA) on a
Hewlett Packard RS-16 IBM compatible PC.
Inactivation
The rate of inactivation was found by assaying the enzyme for activity at
times of 0, 1.5, 3, 5, 10, 15, 20, 30, and 60 minutes after 1 mM pyridoxal
5'
phosphate was added. The enzyme's activity was found by adding 10 uls of the
enzyme mixture to 3 ml of standard assay mix.
Reactivation
From the inactivation mixture, a 200 ml aliquot is taken and separated
from free pyridoxal
5'
phosphate by chromatography on a Sephadex G-25 column.
The enzyme containing fraction was determined from its absorbance at 280 nm
(figure 10). Aliquots of the enzyme containing fraction were assayed using 3 mis of
standard assay mix and the increase in absorbance at 360 nm was monitored on the








Determination of Fraction containing GDH
from Sephadex G-25 Column
trial 1
trial 2
Oe+0 2e + 0 4e+0 6e + 0 8e-i-0
fraction #
Figure 10: Graph of OD (absorbance) at 280 nm vs. fraction number from the
fractions collected on a Sephadex G-25 column. The column was
equilibrated with 0.1 M phosphate buffer pH, 7.0. A 0.2 mL sample
of 0.41 mg/mL solution of glutamate dehydrogenase in 0. 1 M
phosphate buffer, pH 7 was loaded onto the column. One ml




When glutamate dehydrogenase is in the presence of pyridoxal
5'
phosphate,
glutamate dehydrogenase is inactivated as a result of the Schiffs base formed
between the two (figure 1). The rate of inactivation is a function of the relative
rates of kjnact and kreaC{. Since the inactivation is done in the presence of excess
pyridoxal
5'
phosphate, the Schiffs base formation is essentially first order with
respect to the concentration of pyridoxal
5'






Since the reactivation is done without an excess of pyridoxal
5'
phosphate, the rate
observed for the reactivation is the rate of reactivation; kobserved = kreact. The
rate of inactivation can be found once kobserve<i and kreact are both known by:
kinact = (kobserved + kreact^Py*101
5'
PhosPhatel
However, since the rate of reactivation is small compared to the rate
of inactivation





Criteria ForDetermining a Significant Result
For each type of data, the data set with no ligand present was used for
comparison. A result was classified as significant if the magnitude of the average
deviations was less than the difference between the numbers being compared. For
example if with no ligand present the result was 0.20 +/- 0.03 and with a ligand
present the result was 0.30 +/- 0.03, then this would be reguarded as a significant
difference. However if the result with a ligand present was 0.25 +/- 0.03 this
would not be reguarded as a significant result.
Preparation of Selenium NADP+ Analog
Separation o/NAD+from NADP+ using Ion Exchange Chromatography
Materials
AG1-X8 resin was purchased from Bio-Rad Laboratories (Richmond, CA,
U.S.A.). The sodium chloride was purchased from J.T.Baker Incorporated
(Phillipsburg, N.J., U.S.A). Both the cofactors
NAD+
and NADP+ were
purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.). Disposable
culture tubes were bought from VWR Scientific Incorporated (San Francisco, CA,
U.S.A.). An ISCO Model 1200 fraction collector was used to collect fractions.
The OD's were measured on a SLM-Aminco 3000 Array spectrophotometer. Due
to the fact that the plastic cuvettes are not transparent at low wavelengths, quartz
cuvettes made by Fisher Scientific (Fair Lawn, N.J., U.S.A.) were used to measure
the OD at 260 nm.
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Methods
Bio Rad AG1-X8 anion exchange resin was slurried with 0.1 M sodium
chloride solution and packed into Bio Rad column with a radius of 5 cm to a height
of 19 cm. The column was then equilibrated with 100 ml of 0.1 M NaCl solution.
One milliliter containing 1.3 mM
NADP+
and 1.5 mM NAD+ in 0.1 M NaCl
solution was loaded onto the column. Using a gradient formed by a MRA gradient
maker with 55 mL distilled water and 55 mL 1.0 M NaCl solution the cofactors
were eluted from the column and 3 mL fractions were collected in disposable
culture tubes using a fraction collector. The OD at 260 nm of each fraction was




AG1-X8 is a anion exchange resin that is derivatized with quatenary ammonium
groups. Since NADP+ has more negative charge due to its extra phosphate group
we would expect it to bind tighter to the column than
NAD+ (figure 12). To
confirm that NAD+ eluted first and NADP+ eluted last, the above procedure was









AG1-X8 resin was purchased from Bio-Rad Laboratories (Richmond, CA,
U.S.A.). The sodium chloride was purchased from J.T.Baker Incorporated
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OD at 260 nm vs Fraction number
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Figure 11: Graph of OD at 260 nm versus fraction number. The column was




were dissolved in 0.1 M sodium chloride
solution and loaded onto the column. The sample was washed onto
the column with 5-10 mL of 0.1 M sodium chloride solution and eluted
via a gradient formed with 55 mL of distilled water and 55 mL of 1.0
M sodium chloride solution, b) Same procedure was repeated as
described in a but done with a solution of 1.3 mM NAD+. c) Same













Nicotinamide adenine diphosphate (NAD-*)
'NHj
O O



















Nicotinamide adenine cbpfaofphaie phcwphate(NADP*)
Figure 12: Structure of a)NAD+ and b)NADP+at a pH of 6.5. Charges shown
using pKa of primary phosphate as 0.9 and secondary phosphate as 6. 1
and assuming that at a pH of 6.4 that the secondary phosphate has an
equal probability of being protonated since it is not much past its pKa.
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(Phillipsburg, N.J., U.S.A). Both the cofactors NAD+ and NADP+ were
purchased from Sigma Chemical Company (St. Louis, MO, U.S.A.). Disposable
culture tubes were bought from VWR Scientific Incorporated (San Francisco, CA,
U.S.A.). An ISCO Model 1200 fraction collector was used to collect fractions.
Using a gradient maker purchased from MRA (Clearwater, Fl, U.S.A.), the salt
gradient was formed. The salt gradient was determined using an Expandable Ion
Analyzer EA940 made by Orion Research (Cambridge, MA, U.S.A.) with a
Corning sodium selective electrode Model #476210 (Medfield, MA, U.S.A.),
Fisher saturated calomel electrode model # 13-620-57-SN8095112 (Fairlawn, N.J.,
U.S.A.), and an Orion ATC probe Model # 917002 (Cambridge, MA, U.S.A.).
Triethanolamine, the ionic strength buffer, was purchased from Fisher Scientific
(Fair Lawn, N.J., U.S.A.). The OD's were measured on a SLM-Aminco 3000
Array spectrophotometer. Quartz cuvettes made by Fisher Scientific (Fair Lawn,
N.J., U.S.A.) were used to measure the OD.
Methods




peaks. Better resolution can be achieved by either changing the relative
amounts of water and salt to get a slower gradient or by determining the salt
gradient and washing through the column a salt
solution that has a concentration
between that needed to elute
NAD+
and the concentration needed to elute
NADP+. This will cause the
NAD+ to be washed off of the column and the
NADP+
will remain bound. Using this method it is possible to separate the two





The sodium chloride gradient used to elute NAD+ and NADP+ was
determined using a sodium selective electrode. First the column was equilibrated
with 100 mLs of 0.1 M NaCl solution. Three mL fractions of the gradient formed
by a MRA gradient maker using 55 mL distilled water and 55 mL of 1.0 M NaCl
solution were collected. Two ml of each fraction was diluted to 10 mL with
distilled water and then mixed with 10 mL of 0.5 M triethanolamine in order to
bring all the samples to the same ionic strength. Triethanolamine to be used as the
the ionic strength buffer, effectively brings all the samples to the same ionic
strength so that the activity coefficients are equal and the concentration is
proportional to the activity. The Expandable Ion Analyzer by Orion research with
a sodium selective electrode, Fisher saturated calomel electrode, and an Orion
ATC probe was first calibrated. The solutions used to calibrate the ion analyzer
were prepared by mixing 20 mL of sodium chloride solutions with concentrations
of 0.1000M, 0.0100M, 0.0010M and 0.0001M with an equal amount of 0.5 M
triethanolamine resulting in final concentrations of 50.00mM, 5.000mM,
0.500mM, and 0.050 mM. The slope of the resulting calibration curve was 57.2
mV/Dec. Using the sodium selective electrode the concentration of each fraction
was determined. The Expandable Ion Analyzer made by Orion Research with a
Corning sodium selective electrode , Fisher saturated calomel electrode , and an
Orion ATC probe was recalibrated after fraction 20 resulting in a slope of 53.4
mV/Dec and after fraction 26 resulting in a calibration curve of 53.7 mV/Dec using
standards with final concentrations of lOO.OmM, 50.00mM, 5.000mM, 0.5000mM
and 0.0500 mM. The concentration of the fractions collected from the gradient are
shown in figure 13.
From the graph of concentration versus fraction number, the data for the
fractions where the cofactors eluted looked questionable so the Expandable Ion
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Analyzer made by Orion Research with a Corning sodium selective electrode ,
Fisher saturated calomel electrode
, and an Orion ATC probe was recalibrated.
Final concentrations of the standard solutions used to calibrated the ion analyzer
were lOOmM, 50mM, 5mM, 0.5mM and 0.05 mM NaCl. The slope of the
calibration curve was 54.4 mV/Dec. Concentrations of these fractions is shown in
figure 13.
New Protocolfor the Separation ofNAD+ and NADP+
Materials
Same materials as for previous trial.
Methods
From figure 9 we can see that NAD+ eluted mainly in fractions 12 and 13
which we see from figure 11 corresponds to a concentration of 0.059 M NaCl and
NADP+
eluted mostly in fraction 20 which corresponds to a concentration of 0.18
M NaCl. Taking this information into account a new protocol was devised.
The AG1-X8 anion exchange column was equilibrated with 0.1 M NaCl. A
1.3 mM NADP+ and 1.5 mM
NAD+
solution in 0.1 M NaCl was loaded onto the
column. Fifty mL of 0.1 M NaCl was washed through the column to force the
NAD+ down the column. Using a gradient formed using a MRA gradient maker
with 55 mL of distilled water and 55 mL of 1.0 M NaCl solution, the cofactors




















Figure 13: Graph of sodium concentration versus fraction number.
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nm of each fraction was measured to identify the fractions containing cofactors
(figure 14a). The peaks were confirmed by repeating the above procedure using
solutions that contained just NAD+ and NADP+ (see figure 14 b,c).






NAD+ -kinase ((EC 2.7.1.23), type 4 from chicken liver), ATP,
morpholinoethanesulfonic acid and 2-mercaptoethanol were purchased from Sigma
Chemical Company (St. Louis, MO, U.S.A.). A Haake FK constant temperature
water bath was used. The OD's were measured on a SLM-Aminco 3000 Array
spectrophotometer. Quartz cuvettes made by Fisher Scientific (Fairlawn, NJ,
U.S.A.) were used to measure the OD.
Materials used for ion exchange chromatography were as described in the
materials section on page 29.
Methods
In a culture tube 100 uls of 20 mM NAD+, 200 microliter of 10 mM ATP,
5 uls of 1 mM 2-mercaptoethanol, 20ul of 25 mM MnCl2 and 475 uls of 0.5 M
morpholinoethane sulfonic acid buffer, pH 6.5 were added. The reaction mixture
was incubated in a constant temperature bath for 30 seconds at 31C. Addition of
200 uls a 37.4 units ofNAD+-kinase per 200 uls solution initiated the reaction/36)
The reaction was run at 31C for 30 minutes and was then loaded onto the AG1-X8
ion exchange column that had been equilibrated with 0.1 M NaCl. Fifty mL of 0.1
M NaCl was washed through the column. The cofactors were eluted by a sodium
chloride gradient formed by a MRA gradient
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Figure 14: Graph of OD at 260 nm versus fraction number. The column was
equilibrated with 0.1 M sodium chloride solution, a) 1.5 mM
NAD+
and 1.3 mM NADP+ were dissolved in 0.1 M sodium chloride
solution and loaded onto the column. After the sample was loaded
onto the column, 50 mL of 0.1 M sodium chloride solution was washed
through the column and the cofactors were eluted via a gradient formed
with 55 mL of distilled water and 55 mL of 1.0M sodium chloride
solution, b) Same procedure was repeated as described in a but done
with a solution of 1.3 mM NAD+. c) Same procedure was repeated as
described in a but done with a solution of 1.5 mM NADP+.
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maker using 55 mL of distilled water and 55 mL of 1.0 M NaCl. Three mL
fractions were collected and the OD at 260 nm of each fraction was monitored
(figure 15).
Determination ofExtra Peaks in Enzymatic Synthesis
Materials
ATP and ADP were purchased from Sigma Chemical company. All




From a plot of the OD at 260 nm versus fraction number (figure 15) two
additional peaks were discovered. After the realization that ATP and ADP would
also absorb light at 260 nm and that they are also negatively charged (figure 16
a,b), the ion exchange of ATP and ADP were performed using the above
procedure. The results are shown in figure 17.
ADP and ATP were determined to account for one of the additional peaks.
However nothing was done to correct for this since it both elute after the
NADP+
peak. In order to check the reproducibility of the enzymatic synthesis, the
enzymatic synthesis was repeated and the results are shown in figure 18. The












0e+0 1e+1 2e+1 3e+1 4e+1
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Figure 15: Graph of OD at 260 nm versus fraction number of the enzymatic
synthesis reaction mixture. In a culture tube 100 uls of 20 mM
NAD+, 200 uls of 10 mM ATP, 5 uls of 1 mM 2-
mercaptoethanol, 20 uls of 25 mM MnCl2 and 475 microliter of 0.5
M morpholinoethane sulfonic acid buffer, pH 6.5 were added.
The reaction mixture was incubated in a constant temperature bath for
30 seconds at 31C. Addition of 200 microliter of a solution
containing 37.4 units ofNAD
+
-kinase initiated the reaction/36) The
reaction was run at 31C for 30 minutes and was then loaded onto the
AG1-X8 ion exchange column that had been equilibrated with
0. 1 M NaCl. Fifty mL of 0. 1 M NaCl was washed through the
column. The cofactors were eluted by a sodium chloride gradient
formed by a MRA gradient maker using 55 mL of distilled water and
55 mL of 1 .0 M NaCl. Three mL fractions were collected and the OD



























Figure 16: Structure of a) ADP and b) ATP at a pH of 6.5. Charges shown using
pKa of primary phosphate as 0.9 and secondary phosphate as 6.1 and
assuming that at a pH of 6.4 that the secondary phosphate has an equal
probability of being protonated since it is not much past its pKa.
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4.006-1
OD at 260 nm vs Fraction number
of ADP and ATP
2e+1 3e+1 4e + 1 5e+1
Fraction #
Figure 17: Graph of OD at 260 nm versus fraction number. The column was
equilibrated with 0.1 M sodium chloride solution, a) 1 mM ATP was
dissolved in 0. 1 M sodium chloride solution and loaded onto the
column. After the sample was loaded onto the column, 50 mL of 0. 1
M sodium chloride solution was washed through the column and the
cofactors were eluted via a gradient formed with 55 mL of distilled
water and 55 mL of 1.0 M sodium chloride solution, b) Same








OD at 260 nm vs Fraction number
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Figure 18: Graph of OD at 260 nm versus fraction number of the enzymatic
synthesis reaction mixture for trial 1 and 2. Reproducibility is








to Use for Inactivation
First, the appropriate pyridoxal
5'
phosphate concentration to study the
reactivity of lys-126 was determined in experiments where varying concentrations
of pyridoxal
5'
phosphate were incubated with a fixed enzyme concentration. At
the end of the incubation period, aliquots were assayed for activity using the
standard assay protocol described on pages 25-26.
From the plot of the activity vs pyridoxal
5'
phosphate concentration (figure
19), it was determined that a pyridoxal
5'
phosphate concentration of 1 mM results
in approximately 90% inactivation of glutamate dehydrogenase. Since these results
were obtained with an enzyme concentration of 7.3 uM per active sites (i.e. the
concentration of pyridoxal
51
phosphate is 136 fold excess over the enzyme), we
have analyzed the rates of inactivation reported below in terms of a pseudo first
order reaction.
Determination of the Rate ofInactivation




The time course of inactivation of glutamate dehydrogenase by pyridoxal
5'
phosphate was determined for a 0.41 mg/mL (7.3 uM per active site)
gluta-
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0e+0 1e+0 2e+0 3e+0 4e+0
PLP]
Figure 19: Effects of the concentration of pyridoxyl
5*
phosphate on the
inactivation of glutamate dehydrogenase by pyridoxylation. A 0.41
mg/mL solution of glutamate dehydrogenase in 0.1 M phosphate
buffer, pH 7 was incubated with different concentrations of pyridoxyl
5'
phosphate varying from 0 to 3 mM in 0. 1 M phosphate buffer, pH
7. After 1 hour the mixture was assayed for activity.
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mate dehydrogenase with 1 mM pyridoxal
5'
phosphate. The absorbance at 360 nm
vs time data at each incremental assay point resulted in straight lines (figure 20).
The rate analysis software of the SLM-AMINCO3000 was used to calculate rates
from the data. The plot of the rate ys time is shown in figure 21 and the apparent
rate of inactivation was found by fitting the data to an exponential using SigmaPlot
4.0. The rate of inactivation was determined from the equation
'cinact=lcobserved/IPyridoxal
5'
phosphate]. For quadruplicate determinations the
average rate of inactivation was found to be 0.15 mM"U min~l with an average
deviation of 0.02.
Determination of the Rate of Inactivation of
Glutamate Dehydrogenase by Pyridoxal
5'
Phosphate
In Presence of VariousModulators
The effects of various modulators on the inactivation were studied using
similar techniques. The results are tabulated in table 1.
During the course of the above study, the slope of the OD at 360 nm vs time
graph became negative towards the end of the time course when the activity of the
enzyme was low. Since this can not be a property of glutamate dehydrogenase and
pyridoxal
5'
phosphate absorbs at 360 nm (see figure 22 for spectrum), the effect




A blank was made up consisting only of 1 mM pyridoxal
5'
phosphate and
0.1 M phosphate buffer, pH 7. Ten microliters of the blank was assayed into
cuvettes containing 3 mis of standard assay mix consisting of 20 mM glutamate and
250 uM
NAD+
















Tine ( seconds )
Figure 20: Absorbance at 360 nm versus time lines obtained from the applications
package of the SLM-AMINCO 3000 Array at the various incremental
assay points of the incativation of 7.3 uM per active site glutamate
dehydrogenase by 1 mM pyridoxal
5'
phosphate buffer, pH 7.
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Figure 21 : The time course of inactivation of 7.3 uM per active site
glutamate dehydrogenase by 1 mM pyridoxyl
5'
phosphate in 0.1 M
phosphate buffer, pH 7 with no ligands present. The rate of enzyme
activity was determined by dividing the slope of the OD at 360 nm
versus time data by 6.22 cm
_1 mM _1, the extinction coefficient of
NADH. The rate of glutamate dehydrogenase activity was then plotted
as a function of time and the apparenent rate constant of inactivation
was determined by fitting the exponential using Sigma Plot 4.0.
48
Table 1 Effects of various modulators and substrate analogs on the time course of
inactivation. Concentration used: 0.5 mM ADP, 100 uM GTP,
5 mM glutarate, 5 mM L-2-hydroxyglutarate, 5 mM 2-oxoglutarate, and 1
mM succinate. All solutions were made in 0. 1 M phosphate buffer. All
inactivations were done with 1 mM pyridoxal
5'
phosphate and 7.3
uM per active site glutamate dehydrogenase. k=observed rate














































































0.25 I 0.01 1 0.00
0.36 1 0.02 I 0.00
0.38 1 0.02 I 0.00







































Figure 22: Spectrum from 300 to 500 nm of a 1 mM pyridoxyl
5'
phosphate
solution in 0. 1M phosphate buffer pH 7 taken on the SLM-AMINCO
3000 Array spectrophotometer.
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The absorbance at 360 nm versus time lines obtained are shown in figure 23. The
slopes of these lines are listed in table 2. A negative slope for the OD at 360 n vs
time graph was obtained suggesting that pyridoxal
5'
phosphate is responsible for
the "negative rate of enzyme
activity"
observed. This decrease was determined to
be constant over the time course of modification. In order to correct for this, the
average rate of decrease in pyridoxal
5'
phosphate absorbance was subtracted from
each point on the rate ys time graph from the inactivation. Table 3 summarizes the
results after the data has been corrected for the decrease in absorbance due to
pyridoxal
51
phosphate (figure 23). Since a constant was subtracted from the data,
the rates remain essentially the same, however the percent residual activity changed
significantly to positive values which are more credible.
In order to characterize the source of this decrease in absorbance in the
presence of pyridoxal
5'
phosphate, additional experiments were performed.
Pyridoxal
5'
phosphate is known to be sensitive to light and also is known to form a
Schiffs base with free amino groups. The decrease in absorbance could be a result
of either or both. Under the conditions used for this study it is possible for either to
occur. The assay mix containing pyridoxal
5*
phosphate is exposed to light at 360
nm which is near the absorption maxima of pyridoxal
5'
phosphate. In addition,
the assay mix contains two non-enzymatic sources of amine groups, the amine
group on glutamate and the amine group
on the adenine ring of NAD+, both of




Schiffs base formation between pyridoxal
5'
phosphate and lys-126 of glutamate
dehydrogenase results in the loss of enzymatic activity. The enzymatic activity was
measured by monitoring at 360 nm for the production of NADH, at various times
during the inactivation. Towards the end of the time course
of inactivation most of
the enzyme molecules are modified by pyridoxal
5'
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Figure 23: Absorbance at 360 nm versus time lines obtained from the applications
package of the SLM-AMTNCO 300 Array of the pyridoxal
5'
phosphate blank assayed into 3mL of standard assay mix containing
250 uM NAD+ and 20 mM glutamate at the various
incremental time points. Note the decrease in absorbance is constant
over time.
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Table 2 Time Course of "Inactivation" ofBlank
10 ul aliqout of a 1 mM solution of pyridoxal
5'
phospahte was
assayed at times of 0, 1.5, 3, 5, 10, 15, 20, 30, and 60 minutes. The OD
at 360 nm was monitored and the rate of change in the absorbance was
determined using the rate analysis program on the SLM-AMINCO 3000 to













Table 3 Effects of various modulators and substrate analogs on the time course of
inactivation. This data has been corrected for the decrease in absorbance
due to pyridoxal
5'
phosphate. Concentration used: 0.5 mM ADP, 100
uM GTP, 5 mM glutarate, 5 mM L-2-hydroxyglutarate, 5 mM 2-
oxoglutarate, and 1 mM succinate. All solutions were made in 0.1 M
phosphate buffer. All inactivations were done with 1 mM pyridoxal
5'
phosphate and 7.3 uM per active site of glutamate dehydrogenase.
k=observed rate constant of inactivation; A0=amplitude of the
exponential; and B=residual of the exponential.
iModulatorl t
-I
Ho <% red actlavgKobs*
4 1
I-
I none ) 0.1244 i 0.0048 I 0.0007 I 13.25 I
' 1 1 ) |
]__"?"
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0.1713 I M0 1 0.0004 I 7.67 I 0.1496
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I | , , , (
I GTP I 0.2765 I 0.0041 t 1.9E-04 J 4.41 i 0.2926
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IL-H-Glutal 0.2927 \ 0.0028 i 2.7E-04 I
j 1 , , ,_
IL-H-Glutal 0.1944 I 0.0020 I 3.5E-04 1 14.83 I
\ 1 , j , , 0 . 27 6 B
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Thus at the end of the time course very little increase in the OD at 360 nm due to
the production of NADH will be observed. However the excess pyridoxal
5'
phosphate is still available to be either photo-oxidized and/or form a Schiffs base
with glutamate and/or NAD+. Both options would result in a decrease in the
absorbance at 360 nm. In order to determine the cause of the decrease in
absorbance, the pyridoxal
5'
phosphate blank was assayed in a cuvette containing
just 250 uM NAD+ in 0.1 M phosphate buffer at pH 7 at times of 0, 1.5, 3, 5,
10, 15, 20, 30, and 60 minutes. A decrease in absorbance was observed and this
rate of decrease was again constant over time. However the decrease in the absence
of glutamate in the assay mix was only -0.00399
min-1
compared to -0.00513
with glutamate present. This suggests that Schiffs base formation between
pyridoxal
51
phosphate and glutamate contributes to the decrease in absorbance.
The remainder of the decrease could be a result of the photo-oxidation of pyridoxal
5'
phosphate.
Time Course ofReactivation ofPyridoxylated
Glutamate Dehydrogenase with No Modulator Present
Since the inactivation of glutamate dehydrogenase by Schiffs base
formation with pyridoxal
5'
phosphate is a reversible process, the rate of
reactivation was determined. After the completion of the inactivation, an aliquot of
the reaction mixture was run through a Sephadex G-25 column equilibrated with






phosphate allows for the following reaction to occur.
^react
>
GDH-PLP GDH + PLP
<
^inact
Since no excess pyridoxal
5'
phosphate is present the dissociation is
essentially irreversible and the enzyme should regain activity. The rate of this
reactivation was determined by assaying for enzyme activity over a two hour time
period and fitting the resulting rate vs time data (figure 24) to a single exponential
function. The rate of reactivation with no modulator present was found to be 0.02
min"1
with a average deviation of 0.01.
Time Course ofReactivation ofPyridoxylated Glutamate
Dehydrogenase In Presence of Various Modulators
The effects of the various modulators on the reactivation of pyridoxylated
glutamate dehydrogenase were determined using procedures similar to the ones
above.
The rates of reactivation are summarized in Table 4.
In our study we observed no effect on the reactivation of pyridoxylated
glutamate dehydrogenase by the various modulators.
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Rate of Reactivation of Pyridoxylated
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Figure 24: Time course of reactivation after being modified with 1 mM pyridoxal
5'
phosphate for 1 hour. Pyridoxylated glutamate dehydrogenase was
assayed for activity at times of 0, 5, 10, 15, 20, 30, 60 and 120
minutes. The slope of the OD at 360 nm versus time data at each
incremental assay point was divided by the extinction coeffiecient of
NADH and the resulting rate of enzyme activity versus time graph is
shown for the reactivation done in the presence of 20 mM 2-
oxoglutarate.
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Table 4 Effects of the various modulators on the time course of reactivation. A
Sephadex G-25 column was equilibrated with one of the following: 2.5
mM ADP, 300 uM GTP, 20 mM glutarate, 20 mM L-2-
hydroxyglutarate, 10 mM 2-oxoglutarate, and 5 mM succinate. All
solutions were made in 0. 1 M phospahte buffer. Reactivation was
monitored after 7.3 uM per active site of glutamate dehydrogenase
was incubated with 1 mM pyridoxal
5'
phospahte for 1 hour. k=rate
constant of reactivation; A^amplitude of the exponential; and B=the
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Preparation of Selenium NADP+ Analog
Separation ofNAD+ from NADP+ using Ion Exchange Chromatography
Using the procedure described on page 29 (see figure 11) it is obvious that
resolution was not achieved. To achieve better resolution, the salt concentrations




was determined (figure 13) using the procedure described on
pages 33-35. From figure 13 we can see that NAD+ eluted at a concentration of
0.059 M NaCl and NADP+ eluted at a concentration of 0.18 M NaCl.
A new protocol was devised using this information. Resolution is greatly
improved using this protocol as can be seen from the OD at 260 nm versus fraction
number graph (figure 14).
Enzymatic Synthesis ofNADP
+ from NAD+ using NAD
+
-Kinase







-kinase. Two trials were
performed and the trials were reasonable reproducible considering the difficulty




Effects on the Rate Constant ofModification
The rate constant of inactivation of 0.41 mg/ml (7.3 uM per active site)
glutamate dehydrogenase by 1 mM pyridoxal
5'
phosphate in 0.1 M phosphate
buffer, pH 7 was determined to be 0.15 +/- 0.02 sec"l. No effect was observed on
the rate constant of inactivation of glutamate dehydrogenase by pyridoxal
5'
phosphate when the inactivation was done in the presence of the substrate analogs
(see figure 25) L-2-hydroxyglutarate (kinact=0.28 +/- 0.12 sec-1) or succinate, a
four carbon dicarboxylic acid (kjnact=0.16 +/- 0.01 sec"2). In the presence of the
product of the oxidative deamination reaction, 2-oxoglutarate, the rate constant of
inactivation was discovered to be 0.23 +/- 0.07. Within experimental error the
rate constants with 2-oxoglutarate and no modulator are indistinguishable. A slight
increase in the rate constant of inactivation of glutamate dehydrogenase by
pyridoxylation is observed when the enzyme is modified in the presence of
glutarate, a five carbon, catalytically inactive substrate analog of glutamate. With
glutarate present a rate constant of inactivation of 0.22 +/- 0.03 is obtained. Con
sidering the magnitude of the errors of this determination and that with no
modulator present, the rate constant for inactivation in the presence of glutarate is,
statistically, significantly faster than that with no modulator present. With the
exception of glutarate, the substrate analogs have little if any affect on the rate























































































Figure 25: Structures of substrate analogs: a) L-glutamate; b) 2-oxoglutarate; c)
glutarate; d) 2-D-hydroxyglutarate; e) 2-L-hydroxyglutarate and f)
succinate.
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The effects of the purine nucleotides ADP and GTP (see figure 26) were
also investigated. When the modification is done in the presence of ADP the rate
constant of inactivation is greatly increased to 0.33 +/- 0.08 sec"2. GTP brings
about a similar increase in the rate constant of inactivation to 0.29 +/- 0.03 sec"1.
Both purine nucleotides facilitate inactivation of glutamate dehydrogenase by
pyridoxal
5'
phosphate. This observed increase in the rate constant of inactivation
of the enzyme could be the result of the binding of the purine nucleotide resulting
in an induced conformational change in glutamate dehydrogenase leading to a
greater accessibility of lys-126 toward modification by pyridoxal
5'
phosphate
(figure 27a). Another possibility is that the pK of lys-126 could change due a
conformational alteration, resulting in the lys-126 being in either the protonated or
deprotonated form, enhancing the reactivity of this lysine residue (figure 27b)
Preliminary results show no pH dependence on the reactivity of lys-126
toward pyridoxylation. Studies done by Schellenberg and Metzler revealed that
Schiffs base formation with free lysine was also independent of pH.(35>36) Both
our preliminary results and previous work done by others strongly suggest that the
increase in the rate of inactivation by pyridoxal
5'
phosphate is not due to a change
in pK of lys-126
,
but the result of greater accessibility due to an induced
conformational change.
Since modification of glutamate dehydrogenase by pyridoxal
5'
phosphate is
a result of reversible Schiffs base formation, the effects of the various modulators
and analogs on the reactivation was examined as well. With no ligands present, the
rate of reactivation was determined to be 0.021 +/- 0.013. In the presence of
modulators ADP and GTP, the rate of reactivation was found to be 0.039 +/-
0.010 and 0.028 +/- 0.001 respectively. The purine nucleotides thus have no















Figure 26: Structure of allosteric regulator: a) GTP and b) ADP
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a)











Figure 27: Conformational effects of the binding of the purine nucleotides.
a)Binding of the purine nucleotide to glutamate dehydrogenase results
in a conformational change resulting in greater accessability of
lys-
126.
b)Binding of the purine nucleotide to glutamate dehydrogenase results
in a conformational change where lys-126 is in a more reactive form
due to a change in its pK as a result of a local environment effect.
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dehydrogenase.
Various substrate analogs were also examined for their effects on the
reactivation of glutamate dehydrogenase. The rate constant of reactivation in the
presence of succinate was determined to be 0.018 +/- 0.004. When L-2-
hydroxyglutarate, glutarate or 2-oxoglutarate were independently present in the
reactivation mixture, the rate constants of reactivation were determined to be 0.026
+/- 0.004, 0.030 +/- 0.006, and 0.027 +/- 0.002 respectively. From our studies
neither the purine nucleotides nor the substrate analogs exhibited any effect on the
rate constant of reactivation of pyridoxylated glutamate dehydrogenase suggesting
that either the modified enzyme can no longer bind these ligands or, if the modified
enzyme can bind these ligands, any conformational changes resulting from the
binding of these ligands do not affect the ability of the Schiffs base to dissociate.
Effects of the Ligands on the Extent ofModification
The effects of the various ligands on the percent residual activity after
modification of glutamate dehydrogenase by pyridoxyl
5'
phosphate was also
investigated. With no modulator present in the inactivation mixture, the percent
residual activity(% R.A.) was determined to be
9%+/- 3%. When the purine
nucleotides, ADP and GTP were present the % R.A. were discovered
to be 7% +/-
5% and 7% +/- 2% respectively. ADP and GTP have no effect on the extent of
modification of glutamate dehydrogenase by pyridoxal
5'
phosphate. This
observation is consistent with work published by Chen and Engel/37-38)
The consequences of substrate analogs on the percent residual activity were
also determined. With L-2-hydroxyglutarate present, the % R.A. was found to be
16 +/- 9. Due to the magnitude of the average deviation, no conclusions can be
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drawn. The presence of glutarate results in a % R.A. of 22% +1-5%, indicating a
large increase in the residual activity at the end of the modification of glutamate
dehydrogenase by pyridoxal
5'
phosphate. 2-oxoglutarate, the product of the
oxidative deamination reaction of glutamate dehydrogenase, leads to a percent
residual activity of 35% +1-5% which is even larger than that of glutarate. The
four carbon dicarboxylic acid analog, succinate, has no effect on the percent
residual activity as indicated by the result of 9% +/- 6% residual activity. With
the exception of succinate and possibly L-2-hydroxyglutarate, the substrate analogs
result in a higher percent residual activity remaining after modification with
pyridoxyl
5'
phosphate for one hour.
Conclusions aboutADP and GTP
When bound in the absence of other ligands both purine nucleotides, ADP
and GTP, increase the rate constant of inactivation of glutamate dehydrogenase by
pyridoxal
5'
phosphate. The observed increase in the rate constant is comparable
for both GTP and ADP. This suggests that both ADP and GTP have similar con
formational effects on the enzyme at least in the vicinity of lys-126. GTP has
historically been regarded as a potent inhibitor and under most conditions it is.
ADP has both inhibitory and activatory effects on the glutamate dehydrogenase
depending on the conditions. Recently, however, GTP has been suggested to show
effects similar to ADP when present at low concentrations of cofactor (conditions in
which GTP will bind to only one of the two or more potential binding sites(40)).
The results of the current work demonstrate that ADP and GTP have similar effects
when either ADP or GTP is bound to only one of their two or more potential
bining sites, providing the first supporting evidence for this suggestion.
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The effects of ADP and GTP on the residual activity was previously
investigated by Chen and Engel.(38>39) Our results are in agreement with their
finding that the purine nucleotides have no effect on the residual activity. Chen and
Engel also demonstrated that in the presence of the reduced cofactor NAD(P)H,
GTP lessened the extent of the inactivation however no rate constants were
reported. In the presence of NAD(P)H, GTP is known to have at least two binding
sites while in the absence of NAD(P)H, GTP has only a single binding site
available. (39> The protection of modification of lys-126 when both NAD(P)H and
GTP are present could be a result of a conformational change triggered by the
ternary complex preventing lys-126 from being modified by pyridoxal
5'
phosphate. Another possibility is that either the NAD(P)H or GTP binding sites are
close to the substrate binding site resulting in lys-126 being blocked.
Conclusions about Five Carbon Dicarboxylic Acid Substrate Analogs
The presence of various substrate analogs in the inactivation mixture had
little effect on the rate constants of inactivation. However, with the exception of
succinate and L-2-hydroxyglutarate, the various analogs resulted in an increase in
the residual activity suggesting that lys-126 is blocked from being modified by
pyridoxal
5'
phosphate, lys-126 is important because it is thought to be involved in
the binding of substrate by forming a salt bridge with its
5'
carboxyl group. Thus
when substrate analogs containing a
5'
carboxyl group are bound to glutamate




If pyridoxylation were performed at saturating substrate concentrations, no
modification by pyridoxal
5'
phosphate at lys-126 would occur. Due to the high
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Figure 28: Model of the active site of Glutamate Dehydrogenase with Glutamate
bound. This model is based on previous work (46), and is constructed
using Alchemy software.
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ionic strength of saturating concentrations, the modification had to be performed at
sub-saturating concentrations of substrate analogs. At subsaturating conditions the
enzyme molecules that have no substrate bound to them are modified by pyridoxal
5'
phosphate. Thus one would expect the rate constant of inactivation in the
presence of substrate analogs to have the same rate constant of inactivation as with
no ligand present which is what was observed. However the residual activity would
be expected to increase due to the concentration of enzyme molecules with bound
substrate analogs because they were protected from modification.
Conclusions about Succinate
Succinate was determined to have no effect on the rate constant of
inactivation indicating succinate does not affect the reactivity of lys-126. The
residual activity of glutamate dehydrogenase in the presence of succinate also
remained the same as with no ligands suggesting that the binding of succinate does
not block lys-126 from being modified. Kinetic studies(41) have indicated that the
four carbon dicarboxylic acid analog binds in a quite different orientation between
two positive charges (figure 29), one shared with the
1'
carboxyl group of the
substrate and its analogs and the other somewhere in the cofactor binding site
(figure 30). The present study clearly supports this by demonstrating that lys-126 is
still available for modification even when succinate is bound.
Summary ofResults.
The effects of the purine nucleotides on the reactivity of lys-126 are a result
of a conformational change making lys-126 more accessible for modification. The
69






Figure 29: Active site of Glutamate Dehydrogenase with both Glutamate and
Cofactor Pyrophosphate bridge shown.
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substrate analogs had no effect on the rate of reaction of lys-126, however, two
major conclusions that can be drawn from the residual activity results. 1) lys-126
must not interact with the 1
'
carboxyl group of dicarboxylic acid substrates as has
been previously suggested and 2) succinate must bind differently than five carbon
dicarboxylic acid substrates.
Preparation of Selenium NADP+ Analog
The ability to separate
NAD+ from NADP+ is essential if an enzymatic
synthesis is going to be used to make
Se-NADP+ from Se-NAD+ . Using a Bio




with good resolution. With the ability to separate
NADP+
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